Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1Advanced Cancers 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Interventional × LY 2275796 × Clear all
NCT01675128 2016-04-25

ISIS 183750 With Irinotecan for Advanced Solid Tumors or Colorectal Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
24 enrolled 21 charts
Gastrointestinal

Colorectal Neoplasms

NCT00903708 2012-07-30

LY2275796 in Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Completed
24 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡